 | • レポートコード：C-GIR20G2974 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「前立腺特異抗原（PSA）テストの世界市場2019年」は、グローバルにおける前立腺特異抗原（PSA）テスト市場を展望するレポートです。前立腺特異抗原（PSA）テストのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・前立腺特異抗原（PSA）テストの市場概観 ・前立腺特異抗原（PSA）テストの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・前立腺特異抗原（PSA）テストの企業別販売動向、市場シェア、市場集中度、競争動向 ・前立腺特異抗原（PSA）テストの世界市場規模 ・前立腺特異抗原（PSA）テストの北米市場分析（アメリカ、カナダ、メキシコ等） ・前立腺特異抗原（PSA）テストのアメリカ市場規模推移 ・前立腺特異抗原（PSA）テストのカナダ市場規模推移 ・前立腺特異抗原（PSA）テストのメキシコ市場規模推移 ・前立腺特異抗原（PSA）テストのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・前立腺特異抗原（PSA）テストのドイツ市場規模推移 ・前立腺特異抗原（PSA）テストのイギリス市場規模推移 ・前立腺特異抗原（PSA）テストのロシア市場規模推移 ・前立腺特異抗原（PSA）テストのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・前立腺特異抗原（PSA）テストの日本市場規模推移 ・前立腺特異抗原（PSA）テストの中国市場規模推移 ・前立腺特異抗原（PSA）テストの韓国市場規模推移 ・前立腺特異抗原（PSA）テストのインド市場規模推移 ・前立腺特異抗原（PSA）テストの東南アジア市場規模推移 ・前立腺特異抗原（PSA）テストの南米市場分析（ブラジル、アルゼンチン等） ・前立腺特異抗原（PSA）テストの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・前立腺特異抗原（PSA）テストの種類別分析/販売量、売上、市場シェア（CLIA法、ELISA法） ・前立腺特異抗原（PSA）テストの用途別分析/市場規模（スクリーニング、治療後モニタリング、その他） ・前立腺特異抗原（PSA）テストの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・前立腺特異抗原（PSA）テストの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Prostate-specific Antigen (PSA) Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate-specific Antigen (PSA) Testing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Prostate-specific Antigen (PSA) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate-specific Antigen (PSA) Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
PerkinElmer
Siemens Healthcare
Boston Scientific Corporation
Beckman Coulter
Bayer AG
Ortho Clinical
Roche
DiaSorin
Tosoh
GE Healthcare
Medtronic
Fujirebio
Endocare
Bristol-Myers Squibb Company
Mediwatch
Sanofi-Aventis SA
Merck＆Co.
BodiTech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
CLIA Method
ELISA Method
Market Segment by Applications, can be divided into
Screening
Post-treatment Monitoring
Other
Table of Contents
1 Prostate-specific Antigen (PSA) Testing Market Overview
1.1 Product Overview and Scope of Prostate-specific Antigen (PSA) Testing
1.2 Classification of Prostate-specific Antigen (PSA) Testing by Types
1.2.1 Global Prostate-specific Antigen (PSA) Testing Revenue Comparison by Types (2019-2024)
1.2.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Types in 2018
1.2.3 CLIA Method
1.2.4 ELISA Method
1.3 Global Prostate-specific Antigen (PSA) Testing Market by Application
1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Global Prostate-specific Antigen (PSA) Testing Market by Regions
1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Prostate-specific Antigen (PSA) Testing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate-specific Antigen (PSA) Testing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate-specific Antigen (PSA) Testing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Prostate-specific Antigen (PSA) Testing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate-specific Antigen (PSA) Testing Status and Prospect (2014-2024)
1.5 Global Market Size of Prostate-specific Antigen (PSA) Testing (2014-2024)
2 Company Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.2 PerkinElmer
2.2.1 Business Overview
2.2.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.3 Siemens Healthcare
2.3.1 Business Overview
2.3.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Boston Scientific Corporation
2.4.1 Business Overview
2.4.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.5 Beckman Coulter
2.5.1 Business Overview
2.5.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer AG
2.6.1 Business Overview
2.6.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer AG Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Ortho Clinical
2.7.1 Business Overview
2.7.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Roche
2.8.1 Business Overview
2.8.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roche Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.9 DiaSorin
2.9.1 Business Overview
2.9.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 DiaSorin Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tosoh
2.10.1 Business Overview
2.10.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tosoh Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.11 GE Healthcare
2.11.1 Business Overview
2.11.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.12 Medtronic
2.12.1 Business Overview
2.12.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Medtronic Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.13 Fujirebio
2.13.1 Business Overview
2.13.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Fujirebio Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.14 Endocare
2.14.1 Business Overview
2.14.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Endocare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.15 Bristol-Myers Squibb Company
2.15.1 Business Overview
2.15.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.16 Mediwatch
2.16.1 Business Overview
2.16.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mediwatch Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.17 Sanofi-Aventis SA
2.17.1 Business Overview
2.17.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.18 Merck＆Co.
2.18.1 Business Overview
2.18.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
2.19 BodiTech
2.19.1 Business Overview
2.19.2 Prostate-specific Antigen (PSA) Testing Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 BodiTech Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Prostate-specific Antigen (PSA) Testing Market Competition, by Players
3.1 Global Prostate-specific Antigen (PSA) Testing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate-specific Antigen (PSA) Testing Players Market Share
3.2.2 Top 10 Prostate-specific Antigen (PSA) Testing Players Market Share
3.3 Market Competition Trend
4 Global Prostate-specific Antigen (PSA) Testing Market Size by Regions
4.1 Global Prostate-specific Antigen (PSA) Testing Revenue and Market Share by Regions
4.2 North America Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
4.3 Europe Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
4.5 South America Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
5 North America Prostate-specific Antigen (PSA) Testing Revenue by Countries
5.1 North America Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
5.2 USA Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
5.3 Canada Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
5.4 Mexico Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
6 Europe Prostate-specific Antigen (PSA) Testing Revenue by Countries
6.1 Europe Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
6.2 Germany Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
6.3 UK Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
6.4 France Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
6.5 Russia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
6.6 Italy Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Countries
7.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
7.2 China Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
7.3 Japan Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
7.4 Korea Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
7.5 India Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
8 South America Prostate-specific Antigen (PSA) Testing Revenue by Countries
8.1 South America Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
8.2 Brazil Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
8.3 Argentina Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
8.4 Colombia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Prostate-specific Antigen (PSA) Testing by Countries
9.1 Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
9.3 UAE Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
9.4 Egypt Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
9.6 South Africa Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
10 Global Prostate-specific Antigen (PSA) Testing Market Segment by Type
10.1 Global Prostate-specific Antigen (PSA) Testing Revenue and Market Share by Type (2014-2019)
10.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Type (2019-2024)
10.3 CLIA Method Revenue Growth Rate (2014-2024)
10.4 ELISA Method Revenue Growth Rate (2014-2024)
11 Global Prostate-specific Antigen (PSA) Testing Market Segment by Application
11.1 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2014-2019)
11.2 Prostate-specific Antigen (PSA) Testing Market Forecast by Application (2019-2024)
11.3 Screening Revenue Growth (2014-2019)
11.4 Post-treatment Monitoring Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2024)
12.1 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast (2019-2024)
12.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Regions (2019-2024)
12.3 North America Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
12.4 Europe Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
12.6 South America Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Prostate-specific Antigen (PSA) Testing Picture
Table Product Specifications of Prostate-specific Antigen (PSA) Testing
Table Global Prostate-specific Antigen (PSA) Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Types in 2018
Figure CLIA Method Picture
Figure ELISA Method Picture
Table Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Application (2014-2024)
Figure Prostate-specific Antigen (PSA) Testing Revenue Market Share by Applications in 2018
Figure Screening Picture
Figure Post-treatment Monitoring Picture
Figure Other Picture
Table Global Market Prostate-specific Antigen (PSA) Testing Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate-specific Antigen (PSA) Testing Type and Applications
Table Abbott Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table PerkinElmer Basic Information, Manufacturing Base and Competitors
Table PerkinElmer Prostate-specific Antigen (PSA) Testing Type and Applications
Table PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Prostate-specific Antigen (PSA) Testing Type and Applications
Table Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Type and Applications
Table Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Prostate-specific Antigen (PSA) Testing Type and Applications
Table Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Prostate-specific Antigen (PSA) Testing Type and Applications
Table Bayer AG Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Ortho Clinical Basic Information, Manufacturing Base and Competitors
Table Ortho Clinical Prostate-specific Antigen (PSA) Testing Type and Applications
Table Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Prostate-specific Antigen (PSA) Testing Type and Applications
Table Roche Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table DiaSorin Basic Information, Manufacturing Base and Competitors
Table DiaSorin Prostate-specific Antigen (PSA) Testing Type and Applications
Table DiaSorin Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Tosoh Basic Information, Manufacturing Base and Competitors
Table Tosoh Prostate-specific Antigen (PSA) Testing Type and Applications
Table Tosoh Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Prostate-specific Antigen (PSA) Testing Type and Applications
Table GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Prostate-specific Antigen (PSA) Testing Type and Applications
Table Medtronic Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Fujirebio Basic Information, Manufacturing Base and Competitors
Table Fujirebio Prostate-specific Antigen (PSA) Testing Type and Applications
Table Fujirebio Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Endocare Basic Information, Manufacturing Base and Competitors
Table Endocare Prostate-specific Antigen (PSA) Testing Type and Applications
Table Endocare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Type and Applications
Table Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Mediwatch Basic Information, Manufacturing Base and Competitors
Table Mediwatch Prostate-specific Antigen (PSA) Testing Type and Applications
Table Mediwatch Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi-Aventis SA Basic Information, Manufacturing Base and Competitors
Table Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Type and Applications
Table Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Merck＆Co. Basic Information, Manufacturing Base and Competitors
Table Merck＆Co. Prostate-specific Antigen (PSA) Testing Type and Applications
Table Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table BodiTech Basic Information, Manufacturing Base and Competitors
Table BodiTech Prostate-specific Antigen (PSA) Testing Type and Applications
Table BodiTech Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Players (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players in 2017
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players in 2018
Figure Global Top 5 Players Prostate-specific Antigen (PSA) Testing Revenue Market Share in 2018
Figure Global Top 10 Players Prostate-specific Antigen (PSA) Testing Revenue Market Share in 2018
Figure Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Regions (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Regions (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Regions (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Regions in 2018
Figure North America Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Europe Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure South America Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table North America Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
Table North America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure North America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure North America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries in 2018
Figure USA Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Canada Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Mexico Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table Europe Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Countries (2014-2019)
Figure Europe Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure Europe Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries in 2018
Figure Germany Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure UK Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure France Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Russia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Italy Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries in 2018
Figure China Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Japan Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Korea Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure India Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table South America Prostate-specific Antigen (PSA) Testing Revenue by Countries (2014-2019)
Table South America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure South America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure South America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries in 2018
Figure Brazil Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Argentina Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Colombia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Share by Countries in 2018
Figure Saudi Arabia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure UAE Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Egypt Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure Nigeria Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Figure South Africa Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) by Type (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue Share by Type (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Type (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Type in 2018
Table Global Prostate-specific Antigen (PSA) Testing Revenue Forecast by Type (2019-2024)
Figure Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Type (2019-2024)
Figure Global CLIA Method Revenue Growth Rate (2014-2019)
Figure Global ELISA Method Revenue Growth Rate (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue by Application (2014-2019)
Table Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application in 2018
Table Global Prostate-specific Antigen (PSA) Testing Revenue Forecast by Application (2019-2024)
Figure Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Application (2019-2024)
Figure Global Screening Revenue Growth Rate (2014-2019)
Figure Global Post-treatment Monitoring Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Prostate-specific Antigen (PSA) Testing Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Prostate-specific Antigen (PSA) Testing Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
Figure Europe Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
Figure South America Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Forecast (2019-2024)
腫瘍特異抗原の世界市場 2019年版：種類別（コーディング領域、非コーディング領域）、用途別（創薬＆開発、診断、臨床および基礎研究、その他） Scope of the Report: The global Tumor-Specific Antigen market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, al…- CEACAM8(抗原遺伝子)市場：世界及び中国市場分析・予測（～2024年） CEACAM8(Antigen gene) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global CEACAM8(Antigen gene) industry with a focus on the Chinese market. The report provides key statistics on the market status of the CEACAM8(Antigen gene) manu…
- 白血球表面抗原CD47市場：世界及び中国市場分析・予測（～2024年） Leukocyte Surface Antigen CD47 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Leukocyte Surface Antigen CD47 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Leukocyt…
- 静脈固有ステント市場：世界及び中国市場分析・予測（～2024年） Venous-specific Stent Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Venous-specific Stent industry with a focus on the Chinese market. The report provides key statistics on the market status of the Venous-specific Stent manu…
- 良性前立腺過形成薬の世界市場 2019年版：種類別（アルファブロッカー、5-アルファレダクターゼ阻害剤、ホスホジエステラーゼ-5阻害剤、その他）、用途別（病院、クリニック、その他） Description Scope of the Report: The global Benign Prostate Hyperplasia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, …